Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0038454 (stroke)
 147,016 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Motor evoked potentials were recorded in 25 patients with ischaemic stroke within 72 hours of onset by transcranial magnetic stimulation. Motor power was graded according to MRC grading and the disability by Ranking scale. The patients could be grouped into those with normal MEPs (Group I) - 5 (20 per cent), those with prolonged CMCT and/or abnormal MEP/CMAP ratios or prolonged interside difference in CMCT on the hemiparetic side (Group II) - 12 (48 per cent) and those with no elicitable cortical MEPs on the hemiparetic side (Group III) - 8 (32 per cent). Patients with greater weakness and disability tended to have more abnormal or absent MEPs. No definite correlation could be seen with the site of infarct and MEP abnormalities. Patients with no elicitable cortical MEPs (Group III) showed no significant improvement in motor deficit at six months follow up. Where as patients in whom normal or abnormal cortical MEPs could be elicited (Group I & II) showed significant improvement. Evaluation of MEPs by transcranial magnetic stimulation early in acute ischaemic stroke can be used to predict stroke outcome.
 ...
PMID:Motor evoked potentials by magnetic stimulation in acute ischaemic stroke : prognostic significance. 2954 7

Patrick obtained his undergraduate degree at McGill University, and received his graduate training in Medicine and Biochemistry at the University of North Dakota. His postdoctoral work was conducted at the University of British Columbia. He joined the Faculty of Medicine, University of Manitoba as an Assistant Professor of Biochemistry in 1979. He was the recipient of a New Investigator Award (1979-85) from the Heart and Stroke Foundation of Canada, followed by a Scientist Award (1985-90) from the MRC/CIHR. These career awards allowed him to devote the majority of his time to research. He was promoted to Associate Professor in 1983 and Full Professor in 1986. He was cross-appointed as Professor of Pathology and participated in the teaching of General Pathology to residents. He was the founding Director of the Centre for Re-search and Treatment of Atherosclerosis at the University of Manitoba and the Winni-peg Health Sciences Centre. Administratively, he was appointed as the Professor and Head of Biochemistry and Medical Genetics (1992-1999), and an Associate Dean in the Faculty of Medicine in 1999 until his retirement in 2010.Professionally, Patrick served as President of the Canadian Biochemical Society, Chair of the Medical Research Council/Canadian Institute of Health Research New Investigator Awards Committee, Chair of the Alberta Heritage Foundation Senior Investigator Awards Committee, Vice-President of the Heart and Stroke Foundation of Manitoba, and Secretary/Treasurer of the Canadian Society for Clinical Investigation. He continues to serve on Editorial Boards of scientific journals, including the Journal of Clinical and Investigative Medicine. He was invested into the Order of Manitoba in 2011.
 ...
PMID:The making of a lipid biochemist. 3039 77

Dysphagia is recorded in approximately a third of ischemic stroke patients and is associated with malnutrition, aspiration, and pneumonia. We report a case study that assessed dysphagia (GUSS, Gugging Swallowing Screen), paralysis (MRC, Medical Research Council), and disability (mRS, modified Rankin Scale) in the AVANT program (Austrian Vietnamese Advancement Neurorehabilitation Treatment) - a collaboration program between Vietnam and Austria to standardize and systemize neurorehabilitation after stroke practice in Vietnam.
 ...
PMID:The Avant Rehabilitation Program and Cerebrolysin for Treatment of Post-Stroke Dysphagia: A Case Report. 3166 24


<< Previous 1 2 3 4